Form 4: Life360 CFO Sells $1.47M in Company Stock Under 10b5-1 Plan

Life360's Chief Financial Officer, Russell John Burke, reported the sale of 16,287 shares of common stock for approximately $1.47 million under a pre-arranged 10b5-1 plan.

Summary

• Russell John Burke, Chief Financial Officer of Life360, Inc. (LIF), reported a transaction involving the company's common stock.
• On August 26, 2025, Burke sold 16,287 shares of Life360 common stock.
• The shares were sold at a weighted average price of $90.42 per share, resulting in total proceeds of approximately $1,472,000.94.
• Individual transaction prices for the shares ranged from $90.07 to $90.72.
• The transaction was made pursuant to a contract, instruction, or written plan for the sale of equity securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
• Following the sale, Burke beneficially owns 63,030 shares indirectly through the Russell John Burke Revocable Trust.
• Burke also directly holds 111,231 restricted stock units (RSUs), each representing a contingent right to receive one share of the Issuer's common stock upon vesting.
• A transfer of 79,317 directly held shares to the Russell John Burke Revocable Trust was also reported, which was exempt from Section 16 pursuant to Rule 16a-13.

Sentiment

Score: 5

Explanation: The filing reports an insider sale by the CFO, Russell John Burke. While insider sales can sometimes be viewed negatively, the transaction was made pursuant to a Rule 10b5-1 plan, indicating it was pre-scheduled and not based on immediate, non-public information. This mitigates the potential negative signal.

Negatives

• Insider selling, even under a 10b5-1 plan, reduces management's direct equity exposure, which some investors may interpret as a slight negative signal.

Risks

• While the sale was pre-planned, a reduction in insider ownership could be perceived by some investors as a signal of potential future challenges or a lack of confidence from management, which could impact investor sentiment.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding the company's future performance or outlook.

Industry Context

This Form 4 filing is a routine disclosure of an insider transaction and does not provide information directly related to broader industry trends or competitive landscape. Insider sales are common across industries for various personal financial planning reasons.

Related Party Transactions

• The Reporting Person transferred 79,317 directly held shares to the Russell John Burke Revocable Trust. This transfer was exempt from Section 16 pursuant to Rule 16a-13.

Stakeholder Impact

• Shareholders may note the reduction in direct ownership by the CFO, although the sale was pre-planned under a Rule 10b5-1 plan, which typically indicates personal financial planning rather than a change in outlook.
• The transfer of shares to a revocable trust changes the form of ownership for a significant portion of the CFO's holdings, which is a matter of public record for transparency.

Next Steps

• The Reporting Person undertakes to provide to the Issuer, any securityholder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full details regarding the number of shares sold at each separate price within the reported range.

Key Dates

Recommendation

The sale of shares by the CFO, Russell John Burke, was conducted under a pre-arranged Rule 10b5-1 plan, which suggests the transaction was for personal financial planning rather than a reaction to new, adverse company information. This Form 4 filing alone does not provide sufficient new information about Life360's operational or financial performance to alter a fundamental investment thesis. Investors should consider this transaction in the context of the company's overall financial health, strategic outlook, and broader market conditions.

Keywords

Life360, LIF, Russell John Burke, CFO, Insider Sale, Form 4, 10b5-1 Plan, Common Stock, Restricted Stock Units